Literature DB >> 24011810

Prediction of compartment syndrome based on analysis of biochemical parameters.

Petr Mitas1, Martin Vejrazka2, Jan Hruby1, Rudolf Spunda1, Ondrej Pecha3, Jaroslav Lindner1, Miroslav Spacek4.   

Abstract

BACKGROUND: The possibility of predicting severe compartment syndrome using simple biochemical parameters was evaluated in a single-center study of 55 patients who presented with acute femoral embolism and who were treated with open surgical embolectomy.
METHODS: Parameters related to tissue damage and oxidative metabolism (i.e., lactate, bilirubin, myoglobin, uric acid, glucose, and fibrinogen) were monitored in ipsilateral femoral vein blood.
RESULTS: Several statistically significant predictors of relevant compartment syndrome after surgical reperfusion were found, including lactate, uric acid, transcutaneous oxygen pressure, bilirubin, intrafascial pressure, and serum myoglobin. Glycemia and serum albumin did not significantly change over time.
CONCLUSIONS: The lactate concentration in femoral vein blood sampled during surgical embolectomy can be used for the stratification of additional postoperative risk of clinically significant compartment syndrome complicating reperfusion after acute embolism of the femoral artery.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24011810     DOI: 10.1016/j.avsg.2012.12.006

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  Factors Associated With Poor Outcomes in Acute Forearm Compartment Syndrome.

Authors:  Dafang Zhang; Stein J Janssen; Matthew Tarabochia; Arvind von Keudell; Brandon E Earp; Neal Chen; Philip Blazar
Journal:  Hand (N Y)       Date:  2019-11-05

2.  Postoperative extremity compartment syndrome in a cancer center: Incidence and risk factors.

Authors:  Max Vaynrub; Omer Or; Esther Drill; May Saulan; Patrick J Boland
Journal:  Surg Oncol       Date:  2021-04-03       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.